GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...

Pendulum Therapeutics latest innovation comes in the form of a GLP-1 probiotic, acting as an appetite suppressor and healthy ...

Coverage for these medications varies widely across plans; while many employers cover GLP-1 for diabetes treatment, fewer ...

In return for his backing when Kennedy largely dropped his independent presidential bid, Trump has said he would allow Kennedy "to run wild" on healthcare, without offering details.

SAN ANTONIO -- Patients with overweight or obesity lost an average one-fifth of their body weight with the highest dose of ...

Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ETCompany ParticipantsJustin Schreiber – Chairman and Chief ...

Q3 2024 Earnings Call Transcript November 6, 2024 WW International, Inc. misses on earnings expectations. Reported EPS is $-0 ...

Orleans Parish District Attorney Jason Williams announced a conviction in the 2020 shooting of an NOPD officer. The film examines the rich architectural legacy that began with early Africans and ...

Elevated IL-10 in diabetes causes capillary obstruction, linked to cognitive deficits. Blocking IL-10 receptors shows promise for improving brain function.

Governor Landry is ready to revamp the Louisiana tax structure in a way that he says will make Louisiana more economically competitive relative to nearby states.

The majority of patients may safely take glucagon-like peptide 1 receptor agonists (GLP-1 RAs) before elective surgery and ...

Eli Lilly and Co.’s recent decision to drop development at phase II of PD-1 agonist peresolimab in rheumatoid arthritis (RA) because of an inadequate benefit-risk profile brought further attention to ...